InsiderSignal.AI

InsiderSignal.ai

KRRO - Korro Bio, Inc.

Insider Purchase by New Enterprise Associates 17, L.P. (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, New Enterprise Associates 17, L.P., serving as 10% owner at Korro Bio, Inc. (KRRO), purchased 207,100 shares at $11.11 per share, for a total transaction value of $2,300,881.00. Following this transaction, New Enterprise Associates 17, L.P. now holds 1,297,893 shares of KRRO.

This purchase represents a 19.00% increase in New Enterprise Associates 17, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 2 days after the trade was made.

Korro Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

New Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P.

10%

New Enterprise Associates 17, L.P. is a venture capital investment fund established as part of New Enterprise Associates (NEA), one of the world's largest venture capital firms with over $25 billion in committed capital[[1]](https://en.wikipedia.org/wiki/New_Enterprise_Associates). NEA 17 is a Delaware-organized limited partnership headquartered in Timonium, Maryland, managed by experienced venture capital professionals including Forest Baskett, Ali Behbahani, Carmen Chang, and others[[2]](https://whalewisdom.com/filing/new-enterprise-associates-17-lp-sc-13da-2025-10-06-neue). The fund operates as part of NEA's broader portfolio strategy, which has invested in nearly 1,000 companies since the firm's founding in 1977, with a particular focus on technology and healthcare sectors[[1]](https://en.wikipedia.org/wiki/New_Enterprise_Associates). NEA 17 functions as a growth-stage investment vehicle designed to identify and support ambitious founders and emerging companies[[6]](https://www.nea.com). As a component of NEA's successive fund structure—which has progressively increased in capital size, with the sixteenth fund raising $3.3 billion in 2017[[1]](https://en.wikipedia.org/wiki/New_Enterprise_Associates)—NEA 17 exemplifies the firm's commitment to long-term value creation through strategic venture investments. The fund's participation in equity positions, such as the recent stake in Spyglass Pharma, Inc., reflects NEA's continued emphasis on backing promising enterprises across diverse industries[[2]](https://whalewisdom.com/filing/new-enterprise-associates-17-lp-sc-13da-2025-10-06-neue).

View full insider profile →

Trade Price

$11.11

Quantity

207,100

Total Value

$2,300,881.00

Shares Owned

1,297,893

Trade Date

Tuesday, March 10, 2026

5 days ago

SEC Filing Date

Thursday, March 12, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Korro Bio, Inc.

Company Overview

No company information available
View news mentioning KRRO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4728353

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime